Cargando…
Serum magnesium, mortality and disease progression in chronic kidney disease
INTRODUCTION: Magnesium disorders are commonly encountered in chronic kidney disease (CKD) and are typically a consequence of decreased kidney function or frequently prescribed medications such as diuretics and proton pump inhibitors. While hypomagnesemia has been linked with increased mortality, th...
Autores principales: | Azem, Rami, Daou, Remy, Bassil, Elias, Anvari, Eva Maria, Taliercio, Jonathan J., Arrigain, Susana, Schold, Jesse D., Vachharajani, Tushar, Nally, Joseph, Na khoul, Georges N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017617/ https://www.ncbi.nlm.nih.gov/pubmed/32050924 http://dx.doi.org/10.1186/s12882-020-1713-3 |
Ejemplares similares
-
Correction to: Serum magnesium, mortality and disease progression in chronic kidney disease
por: Azem, Rami, et al.
Publicado: (2020) -
Urine Sediment Examination: Comparison Between Laboratory-Performed Versus Nephrologist-Performed Microscopy and Accuracy in Predicting Pathologic Diagnosis in Patients with Acute Kidney Injury
por: Fadel, Remy, et al.
Publicado: (2023) -
Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression
por: Cholin, Liza, et al.
Publicado: (2021) -
Dysnatremias, Mortality, and Kidney Failure in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
por: Hassanein, Mohamed, et al.
Publicado: (2022) -
Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999–2004
por: Navaneethan, Sankar D, et al.
Publicado: (2014)